Muendlein et al. [65] demonstrated that plasma ANGPTL4 was higher in patients with metabolic syndrome, and the number of single nucleotide polymorphisms in ANGPTL4 could predict future cardiovascular events. This evidence concerns the gene ANGPTL4 and metabolic syndrome.